par Eggermont, A;Suciu, Stefan ;Testori, Alessandro;Kruit, Wim H;Marsden, Jeremy;Punt, Cornelis;Santinami, M.;Sales, François ;Schadendorf, Dirk;Patel, Poulam;Dummer, Reinhard;Robert, Caroline;Keilholz, Ulrich;Yver, Antoine;Spatz, Alain
Référence European journal of cancer, 48, 2, page (218-225)
Publication Publié, 2012-01
Référence European journal of cancer, 48, 2, page (218-225)
Publication Publié, 2012-01
Article révisé par les pairs
Titre: |
|
Auteur: | Eggermont, A; Suciu, Stefan; Testori, Alessandro; Kruit, Wim H; Marsden, Jeremy; Punt, Cornelis; Santinami, M.; Sales, François; Schadendorf, Dirk; Patel, Poulam; Dummer, Reinhard; Robert, Caroline; Keilholz, Ulrich; Yver, Antoine; Spatz, Alain |
Informations sur la publication: | European journal of cancer, 48, 2, page (218-225) |
Statut de publication: | Publié, 2012-01 |
Sujet CREF: | Cancérologie |
MeSH keywords: | Antineoplastic Agents -- therapeutic use |
Chemotherapy, Adjuvant | |
Clinical Trials, Phase III as Topic | |
Disease-Free Survival | |
Epidemiologic Methods | |
Female | |
Humans | |
Immunologic Factors -- administration & dosage | |
Interferon-alpha -- administration & dosage | |
Male | |
Melanoma -- drug therapy -- mortality -- pathology | |
Neoplasm Staging | |
Polyethylene Glycols -- administration & dosage | |
Predictive Value of Tests | |
Randomized Controlled Trials as Topic | |
Recombinant Proteins -- administration & dosage | |
Skin Neoplasms -- drug therapy -- mortality -- pathology | |
Ulcer -- pathology | |
Note générale: | Journal Article |
Meta-Analysis | |
Research Support, Non-U.S. Gov't | |
SCOPUS: ar.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2011.09.028 | |
info:pii/S0959-8049(11)00787-8 | |
info:scp/84655168007 | |
info:pmid/22056637 |